2025 annual financial data
Aspire Biopharma Holdings 2025 Operating margin
Aspire Biopharma Holdings 2025 operating margin with verified reported values.
Direct answer
Operating margin was -312,016.95%.
Operating income was -19,351,291 USD and net income was -24,480,848 USD.
Operating cash flow was -4,923,488 USD.
Get free Aspire Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,202 USD
- Operating income
- -19,351,291 USD
- Net income
- -24,480,848 USD
- Operating cash flow
- -4,923,488 USD